Intramuscular Injection

Gilead
Pharma

Gilead's PrEP shows early promise in once-yearly dosing

Once-yearly lenacapavir achieved blood concentrations that exceeded those associated with the strong efficacy that its twice-yearly version showed.
Angus Liu Mar 11, 2025 2:30pm
Rubber stamp with FDA and medicine - stock photo BetNoireGetty Images

Jazz secures FDA nod for revised blood cancer dosing schedule

Nov 22, 2022 10:30am